NCT05605171

Brief Summary

Urinary incontinence post radical prostatectomy is a well-recognized complication regardless of approach, with a potential negative impact on health-related quality of life. Although 12-month continence rates range from 85-95% in the literature, few patients are continent in the early postoperative period. It has been suggested that posterior reconstruction of the Denonvilliers' musculofascial plate, also known as the Rocco stitch, may improve early return to urinary continence, though clinical equipoise remains.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
163

participants targeted

Target at P50-P75 for not_applicable prostate-cancer

Timeline
Completed

Started Mar 2014

Typical duration for not_applicable prostate-cancer

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 19, 2014

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2016

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 23, 2019

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

October 23, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 4, 2022

Completed
Last Updated

November 4, 2022

Status Verified

October 1, 2022

Enrollment Period

2.7 years

First QC Date

October 23, 2022

Last Update Submit

October 28, 2022

Conditions

Keywords

Localized prostate cancerRobot-assisted laparoscopic radical prostatectomyVesicourethral anastomosisPosterior vesicourethral anastomosis reconstructionRocco stitchUrinary incontinence

Outcome Measures

Primary Outcomes (1)

  • Return to urinary incontinence

    The validated EPIC-26 (The Expanded Prostate Cancer Index Composite) Short Form (© The University of Michigan).

    12 months post procedure

Secondary Outcomes (1)

  • Need for incontinence improving procedure

    5 years post surgery

Study Arms (2)

Posterior reconstruction urethrovesical anastomosis.

EXPERIMENTAL

The intervention comprised of a 2-stitch approximation of the free edge of the Denonvilliers' fascia and posterior bladder wall cranially, to the posterior aspect of the rhabdosphincter and the posterior median raphe caudally, respectively, following prostate extraction. The aim of this approach is to ultimately restore the length of the urethrosphincteric complex, prevent its caudal retraction, and avoid undue tension on the subsequent vesicourethral anastomosis, and provide a posterior support to the urethral sphincter complex to facilitate its effective contraction.

Procedure: Posterior reconstruction urethrovesical anastomosis.

Conventional urethrovesical anastomosis.

ACTIVE COMPARATOR

The conventional is fashioned with a continuous running technique that uses two sutures. The first suture is passed in a clockwise hemicircumferential manner, starting from outside in on the bladder neck at the 5 o'clock position and inside out on the urethra up toward the 12 o'clock position. The second suture is similarly run in a counter- clockwise hemicircumferential direction. The running sutures are snug down after each apposition to ensure there is no slack, and finally tied together with several knots at the 12 o'clock position.

Procedure: Conventional vesicourethral anastomosis.

Interventions

Rocco stitch.

Posterior reconstruction urethrovesical anastomosis.

Standard of care.

Conventional urethrovesical anastomosis.

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any patient over age 18 (with the ability to give informed consent) with localized prostate cancer (cT1-2, N0, M0).

You may not qualify if:

  • History of previous prostatic and/or urethral surgery
  • A known history of a disease or comorbidity that could affect continence, such as insulin-dependent diabetes or urethral stenosis
  • Presence of a urinary catheter preventing preoperative evaluation of continence.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Prostatic NeoplasmsUrinary Incontinence

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Bobby Shayegan, MD

    McMaster University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor & Head, David Braley & Nancy Gordon Chair in Urology

Study Record Dates

First Submitted

October 23, 2022

First Posted

November 4, 2022

Study Start

March 19, 2014

Primary Completion

November 30, 2016

Study Completion

March 23, 2019

Last Updated

November 4, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share